In a new report, the WHO says financing and access strategies need to be implemented to ensure the demand for future TB vaccines doesn't outstrip supply.
Among non–US-born individuals treated at community health centers, only 1 in 3 were tested for TB.
In high-burden countries around the world, the loss of USAID funding has had a devastating impact on critical TB intervention and treatment efforts.
The Treatment Action Group says the 22 TB projects whose funding was suspended by NIH don't involve "gain-of-function" research.
A randomized trial finds that a 6- to 9-month regimen of bedaquiline, delamanid, linezolid, and clofazimine worked better in pre-XDR TB patients with limited disease.
The results of 2 phase 2b trials suggest sutezolid and delpazolid could provide safer alternatives to linezolid in shorter drug regimens for drug-resistant TB.
In total, 55% of active tuberculosis, 99% of latent tuberculosis, 61% of hepatitis B, 35% of HIV, and 83% of hepatitis C infections were new diagnoses.
The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.
The battery-powered device is the first to detect Mycobacterium tuberculosis in saliva in addition to blood and sputum.
Other trends included worrisome rises in tuberculosis, measles, and pertussis.
